Financials
- Market Capitalization 52.67 M
- Employee 39
- Founded 2015
- CEO Denise Scots-Knight
- Website www.mereobiopharma.com
- Headquarter United Kingdom
- FIGI BBG00KFWZC67
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.25
ratio cours/chiffre d'affaires
121.51
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 4248 | INMB INmune Bio Inc. - Common stock | 2.07 USD | +2.48% | +19.65% | +61.72% | -8.81% | 55.03 M USD | ||
| 4265 | XLO Xilio Therapeutics, Inc. - Common Stock | 9.12 USD | +1.00% | -1.30% | +9.75% | +1149.32% | 52.74 M USD | ||
| 4267 | MCRB Seres Therapeutics, Inc. - Common Stock | 5.45 USD | +2.06% | -24.20% | -9.62% | -33.78% | 52.25 M USD | ||
| 4270 | BYSI BeyondSpring, Inc. - Ordinary Shares | 1.27 USD | -4.51% | -21.60% | -22.09% | -44.30% | 52.22 M USD |